print-logo
Logo
  • Healthcare Consultants
  • Healthcare Managers
  • Who we are Arrow Down
    • About us
    • Our team
    • News & events
  • What we do Arrow Down
    • Overview
    • Market Access
    • Medical Affairs
    • Government Affairs
    • Commercial Excellence
    • Patient Affairs
    • Healthcare Improvement
  • Insights Arrow Down
    • Publications
    • Project cases
    • Early Asset Strategy
    • Value Pull-through
    • Environment Transformation
  • Careers Arrow Down
    • Why join us
    • FAQ
  • Contact
  • Search Icon
  • Healthcare Consultants
  • Healthcare Managers
  • Search Icon
  • Search
Back to Publications
  • linkedin_icon
  • mail_icon
  • print_icon
  • download

Value-Based Healthcare (VBHC) in action: Key takeaways from ICHOM 2023

The ICHOM Conference 2023, the world's largest VBHC event, brought together leaders from the international public and private healthcare sector including pharma, policymakers, payers, providers, patient representatives, academia and MedTech. The conference aimed to continue building momentum for change that matters to patients, and it was a great success. We have summarised our key takeaways from the conference below.

Value-based healthcare: key insights from ICHOM conference 2023

1. VBHC adopters across the globe

“If not us, who? If not now, when?” – OECD & Harvard School of Public Health.

VBHC is happening across the globe. Selected healthcare providers have started to measure and improve outcomes that truly matter to patients. They are leveraging standardised approaches such as the ICHOM sets or PaRIS (patient-reported indicator surveys by OECD) for outcome collection. 

ICHOM pic 3_cropped.jpg

Until today, ICHOM has developed 45 sets of outcome measures that are most relevant to patients – covering nearly 60% of global disease burden. The sets include PROMs, patient-relevant outcome measures capturing symptom burden, functional status and health-related Quality of Life (QoL) as well as clinician-reported outcome measures (CROMS).

They were developed in collaboration with a global expert community and patients. The ICHOM sets have been implemented in over 450 case settings across 42 countries – with Germany and the Netherlands as the leading implementation countries. 

Outcomes-based agreements (OBAs link payment to achievement of treatment outcomes) have proven to be a successful tool for implementing VBHC on the pharma and payer side – who feel a responsibility for managing uncertainties and ensuring healthcare system sustainability. A global pharma company highlighted that OBAs have resulted in timely patient access, positive impact on QoL, and budget predictability. Pharma and payers emphasized the critical success factors for OBAs: 

  • Cross-functional collaboration within pharma
  • Early and long-term stakeholder partnerships between pharma, payers, providers and patients based on trust, transparency, and common goals
  • Alignment on how to measure which patient-relevant outcomes
  • Data and information sharing

2. Remaining challenges for VBHC adoption

VBHC leads to increased efficiency, better resource allocation, and improved patient outcomes than the traditional fee-for-service care models which are characterized by a lack of outcome measures to optimize treatment based on the patient’s needs and preferences. Still, key challenges remain for VBHC adoption.

Limited awareness of VBHC

Different stakeholders including the public, policymakers and patients have often limited awareness and understanding of VBHC. This limited VBHC literacy has effects. For instance, it can limit policymakers’ willingness to prioritize VBHC on the political agenda. 

Limited trust among stakeholders

Pharma, payers, providers and patients explained that there is usually limited trust between stakeholders to collaborate and share outcomes data (PROMs & CROMs). This hinders intersectoral collaboration, cross-sectoral expertise, and successful OBAs. One of the key reasons mentioned for the limited trust is conflicts of interest between various stakeholders.

Healthcare systems under pressure

ICHOM pic 1_cropped.jpg

Providers, policymakers, and payers emphasized that healthcare systems are fragmented, disease-focused and at their limits, delivering disintegrated care with misaligned incentives and hindering OBAs. One of the key incentive issues discussed was that providers often lack financial incentives to measure outcomes and perceive the collection of outcome measures as a burden.

In settings where outcomes are measured, they are often not comparable because measurement standards are not followed or implemented uniformly. This makes it difficult to use the outcomes data for benchmarking, identifying innovators, improving quality of care at large scale, and supporting policy-making. 

3. Solutions to drive VBHC adoption

The challenges presented in adopting VBHC call for concerted efforts from all stakeholders in the healthcare ecosystem. To make VBHC a reality at large scale and reap its benefits, the following actions are imperative:

Developing VBHC educational campaigns

Stakeholders need to be educated on the importance of VBHC, the patient perspective, and the role of data in improving patient outcomes and quality of care. Patient advocacy groups emphasized that VBHC literacy campaigns for the public and policymakers should leverage patient stories: 

“The data make you credible, but the stories make you memorable” – American Heart Association. 

VBHC literacy campaigns should also emphasize the importance of institutionalizing patient involvement in health policy decisions: 

“Nothing about us without us” – UK patient representative. 

Educational campaigns should train healthcare providers on collecting and evaluating PROMs and CROMs in a standardized manner (e.g., following the ICHOM sets). These different campaigns can help to create a VBHC mindset and shift the cultural paradigm among policymakers and healthcare providers. Once providers and policymakers adopt a VBHC mindset, their commitment, conviction, and leadership are required to implement VBHC.

Building trust among stakeholders

Transparency and data quality emerged as the key drivers for trust-building during the conference. While pharma should openly communicate the knowns and unknowns of their products (e.g., real-world effectiveness and budget impact), patients should be given access to their data. Multiple stakeholders highlighted the need for information sharing and an open dialogue to make VBHC work. The trust issue can be overcome with strong stakeholder partnerships and joint initiatives based on common goals and transparency. Trust-building between providers and patients is also considered crucial for enhancing shared decision-making and supporting personalized care.

ICHOM pic 4.jpg

Empowering patients in optimized healthcare systems

The stakeholders are aligned that patients should be involved throughout the research and the care pathway, giving them a voice in trial design and treatment choice. Patients also need to be empowered to be the data generators: 

“My answers matter to the treatments I get” – patient representative. 

Healthcare systems need to be strengthened to respond to the patient voice – ICHOM is currently developing a Patient Charter that patients and healthcare systems can leverage. 

The panel discussions also revealed that healthcare resources should be optimized by directing them towards collecting PROMs (i.e., using patient surveys as diagnostic tools) and improving patient-relevant outcomes. Pharma and providers highlighted that providers need to be incentivised to collect PROMs in a standardized way through compensation that correlates with outcomes. The standardized approach towards PROMs and CROMs collection allows for benchmarking of outcomes which can inform decision-making at different levels. Providers also need better clarity on how the outcomes are integrated into the regular care pathway (e.g., to inform treatment choice). Ultimately, providers that deliver better patient outcomes at competitive costs (e.g., through preventing hospitalization) thrive in VBHC.

Consensus also exists that integrated and secured digital infrastructures are essential for VBHC to work. But remember: 

“Old organization + new technology = expensive old organization” – Dutch healthcare provider. 

ICHOM pic 2_cropped.jpg

New technology at the provider level is needed for efficient PROMSs & CROMs collection, evaluation, sharing, and insights generation. Data-sharing platforms will foster collaboration among stakeholders, and ideally countries and ultimately set the foundation for VBHC to become reality at large scale. 

4. Best practices

Inspirational initiatives of early adopters to showcase VBHC as a solution to current healthcare challenges:

  • The transformation of Saudi Arabia’s healthcare system, moving from an institution-centric towards a patient-centric approach, is a clear example of a country embracing a VBHC mindset. They aim for an integrated healthcare system where cost and outcomes are continuously measured.
  • The Hospital Clinic Barcelona is adopting the VBHC model and implementing the ICHOM sets (for inflammatory arthritis, age-related macular degeneration, hip prostheses, knee prostheses, liver oncology, and upper limb surgery). The quality management team developed tools to collect and integrate PROMs and CROMs and conduct a cost-effectiveness analysis of the different treatment options. 
  • The GluCare Integrated Diabetes Center in Dubai integrates a patient-centric approach with technology to deliver healthcare following the VBHC approach and ICHOM diabetes set. The centre leverages digital platforms to streamline care delivery for diabetes patients.
  • The Michigan Surgical Quality Collaborative (MSQC) supported by the American Blue Cross, has brought together hospitals, clinicians, and researchers to improve surgical outcomes. They share data and best practices, and work collectively to enhance patient care. The initiative has resulted in avoided complications, reduced length of stay and cost savings.
  • The European Society of Cataract and Refractive Surgeons (ESCRS) Registries provide a model of data-sharing platforms. With more than 3 million records collected from 16 countries, the ESCRS Registries are among the most prominent projects in ophthalmology. These registries help track the outcomes and experiences of patients undergoing eye surgery.

Nominated research projects at ICHOM 2023: Winner of VBHC Prize 2023, Winner of NEJM Catalyst price 2023

“Change has never been that fast and will never be that slow again” – Harvard School of Public Health. 

Download PDF 462.5 KB

Contact our experts

Rahel Erlemann

Rahel Erlemann

Senior Consultant

mail_icon linkedin_icon

Related Publications

Publication Preview Image

October 16 2023

Measuring the impact of patient engagement: How pharma can lead the way

Publication Preview Image

September 18 2023

The 5 ‘innovation areas’ driving success in chronic diseases

Publication Preview Image

June 23 2022

The PATH forward: How pharma can drive four key healthcare trends

Publication Preview Image

December 16 2021

All PROs, no cons? Why patient-reported outcomes can ensure the patient voice is fully heard in access decisions

Publication Preview Image

August 03 2020

Value-based healthcare in practice: how far have we come?

Publication Preview Image

October 15 2019

Value-based healthcare: Time to get on board!

Share this page
  • linkedin_icon
  • mail_icon
  • print_icon

We use cookies to ensure we give you the best experience on our website. Detailed information on the use of cookies, and how you can disable them, is provided in our Privacy Policy. By using this site or clicking on "OK", you consent to the use of cookies.

OK
arrow_up

How can we help?

Contact us

Our offices

Careers

Footer Logo
  • Who we are
  • What we do
  • Insights
  • Careers
  • Contact
  • Terms of use
  • Privacy policy
  • Imprint

2025 Executive Insight. All rights reserved.